This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43686202
rdf:type
wikibase:Item
schema:description
article scientifique научна статия 2001年學術文章 επιστημονικό άρθρο scientific article published in August 2001 wetenschappelijk artikel מאמר מדעי научни чланак 2001年学术文章 আগস্ট ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico мақолаи илмӣ სამეცნიერო სტატია vedecký článok articolo scientifico 2001年學術文章 videnskabelig artikel naučni članak tudományos cikk 2001年学术文章 artículo científico publicado en 2001 наукова стаття, опублікована в серпні 2001 научная статья artigo científico teaduslik artikkel 2001年學術文章 vědecký článek scientific article published in August 2001 научни чланак artikull shkencor vitskapeleg artikkel 2001年学术文章 artykuł naukowy bilimsel makale tieteellinen artikkeli articol științific 2001년 논문 artikel ilmiah 2001年學術文章 article científic บทความทางวิทยาศาสตร์ wissenschaftlicher Artikel scienca artikolo 2001年学术文章 2001 nî lūn-bûn مقالة علمية نشرت في أغسطس 2001 artigo científico vitenskapelig artikkel artículu científicu espublizáu en 2001 2001年の論文 bài báo khoa học 2001年學術文章 scientific article published in August 2001 article scientific artikulong pang-agham 2001年学术文章 2001年学术文章 vetenskaplig artikel
p:P577
wds:Q43686202-97B6CACD-AC20-4B0D-867A-9B1CA85D936B
wdt:P577
2001-08-01T00:00:00Z
p:P2860
wds:Q43686202-00C455DE-C2BE-4A30-94E9-8DE08BF232AA wds:Q43686202-3A445DDA-176A-44CE-93E4-E5E2F12FCF6F wds:Q43686202-3D7630E0-99E9-4BA4-93F5-9A2B33936235 wds:Q43686202-591C6732-E895-454F-8E50-B30A9AAF0E05 wds:Q43686202-1DF4E5F1-ABE5-4D25-888E-4F668B395172 wds:Q43686202-2145C411-6F3F-40E9-B159-F20405C05334 wds:Q43686202-2CF871CA-24F1-4E23-A0C9-5C7DDC6F8CD4 wds:Q43686202-2DC1C79C-23FB-41EE-B057-E41C2AEE517E wds:Q43686202-8F2B3511-99F5-4F3B-B624-7E541625F408 wds:Q43686202-910D22A4-A544-4F06-8429-C4DB9B7D92C8 wds:Q43686202-67FC551C-B61A-45EE-AD80-A23239EE56CB wds:Q43686202-74FF8EE1-048D-445B-8906-1ADD29BAE154 wds:Q43686202-A2264371-3B46-4F85-A56E-4A60FA67F30B wds:Q43686202-A67960FF-DCA2-40CA-B219-653AA342BA93 wds:Q43686202-AC40BD23-1B19-4CDD-81F5-AFD3718AC4F1 wds:Q43686202-B2B18CC9-C74A-4417-921A-20CFD4CD7701 wds:Q43686202-951F0D7D-17BF-42D4-B7E6-A49EB3E4CC77 wds:Q43686202-9A3BB587-387E-4618-9DFF-146141049844 wds:Q43686202-D3902646-BD8C-494A-9FF6-54D8AD040B3F wds:Q43686202-DB583290-98CB-4DCD-916E-1AD3679E5CC6 wds:Q43686202-FE59CE8E-2257-437B-AB0B-EE424F382E80 wds:Q43686202-B944F551-6888-4286-9EB0-B00940CE0C23 wds:Q43686202-C234D8E7-727A-45E2-9ED8-713882B4F006
wdt:P2860
wd:Q50754964 wd:Q72924060 wd:Q42556526 wd:Q73155961 wd:Q42555519 wd:Q72546475 wd:Q70760027 wd:Q53960639 wd:Q50988343 wd:Q78245024 wd:Q53922529 wd:Q53974150 wd:Q37309885 wd:Q78410437 wd:Q48892833 wd:Q48848054 wd:Q54017281 wd:Q48823783 wd:Q78925918 wd:Q69774026 wd:Q68005498 wd:Q50755447 wd:Q48387731
p:P2093
wds:Q43686202-D16385D7-FA3D-42BD-BC77-530FC06C42F3
wdt:P2093
Larsson LI
rdfs:label
Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension
skos:prefLabel
Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension
schema:name
Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension
p:P1476
wds:Q43686202-79144500-491E-4E3B-A570-8535A0EA9C62
wdt:P1476
Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension
p:P304
wds:Q43686202-5CCA5D34-EA6F-4ED2-91D9-B7715E86C406
wdt:P304
1439-1444
p:P31
wds:Q43686202-08219DF4-AD5C-40DC-ABC8-3455BB710BBE
wdt:P31
wd:Q13442814
p:P921
wds:Q43686202-C9E4A51F-09D9-4A4D-ABE8-61E9A84DF692
wdt:P921
wd:Q634959
p:P698
wds:Q43686202-DA43895E-5D93-4152-85EA-3B581BDAFBDB
wdtn:P698
n9:11470697
wdt:P698
11470697
p:P1433
wds:Q43686202-94F50AF4-C6C2-4103-B61F-C9CEF71BE264
wdt:P1433
wd:Q7098109
p:P433
wds:Q43686202-8E6019BF-B3E2-42FD-95C0-1B00F5FCDF0F
p:P478
wds:Q43686202-311BD355-4E77-4744-9271-54CEB1E04C1C
wdt:P433
8
wdt:P478
108
p:P356
wds:Q43686202-8C013F56-0110-4ED1-B341-CC4AC49ACED9
wdtn:P356
n10:S0161-6420(01)00605-4
wdt:P356
10.1016/S0161-6420(01)00605-4